| Line Item | 2024-03-30 | Y/Y |
|---|---|---|
| Revenue | $3.77B | +5.6% |
| Cost of Revenue | $2.28B | +0.4% |
| Gross Profit | $1.49B | +14.8% |
| R&D Expense | $682.2M | +5.0% |
| SG&A Expense | $389.1M | +8.5% |
| Operating Income | $91.7M | -49.9% |
| Interest Expense | $69.2M | +1.1% |
| Pre-tax Income | $73.6M | -41.0% |
| Income Tax | $143.9M |
| Line Item | 2024-03-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | +27.3% |
| Accounts Receivable | $413.0M | +35.6% |
| Inventory | $710.6M | -10.8% |
| Current Assets | $2.45B | +20.5% |
| Total Assets | $6.55B | -2.1% |
| Current Liabilities | $1.23B | +121.3% |
| Long-term Debt | $1.55B | -24.4% |
| Line Item | 2024-03-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $833.2M | -1.2% |
| Capital Expenditures | $127.2M | -20.0% |
| Investing Cash Flow | -$136.5M | +11.0% |
| Financing Cash Flow | -$459.6M | +46.1% |
| Free Cash Flow | $706.0M | +3.2% |
| +569.9% |
| Net Income | -$70.3M | -168.2% |
| EPS (Basic) | -$0.72 | -171.3% |
| EPS (Diluted) | -$0.72 | -172.0% |
| Total Liabilities |
| $3.00B |
| +7.5% |
| Stockholders' Equity | $3.56B | -8.9% |